ArticleFrontiers in neurology
MRI markers of glymphatic dysfunction in tuberculous meningitis: associations with CSF proteins and cognitive impairment.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Tuberculous meningitis (TBM), a central nervous system infection, is frequently complicated by mild cognitive impairment (MCI). Although imaging markers of glymphatic function have been shown to correlate with cognitive decline, its role in TBM remains unrevealed. This study aims to examine the associations among glymphatic function, cognitive performance, and cerebrospinal fluid proteins in patients with TBM using functional magnetic resonance imaging (fMRI). Methods: This study enrolled 123 participants (61 healthy controls (HCs), 30 TBM-nonMCI, 32 TBM-MCI) who underwent MRI scanning and cognitive assessments. The perivascular space (PVS) load, diffusion-tensor imaging along the perivascular spaces (DTI-ALPS) index and choroid plexus volume (CPV) were calculated to evaluate lymphatic function. CSF proteomics were analyzed in TBM patients. Then, partial correlation and mediation analyses examined the associations among CSF proteins, lymphatic metrics, and cognition. Receiver operating characteristic curves were used to evaluated the predictive capacity for TBM-MCI diagnosis and 6-to 12-month treatment outcomes. Results: Compared with HCs, all patients showed smaller hippocampal PVS volume fraction and larger CPV, and the TBM-MCI group exhibited lower ALPS and higher basal ganglia PVS. ALPS indices positively correlated with cognitive measures (SDMT, MMSE), while hippocampal PVS positively correlated with multiple cognitive domains; CPV exhibited opposite correlations. The right CPV fully mediated the relationship between the right ALPS-MMSE and the right ALPS index, distinguishing TBM-MCI from HCs (AUC = 0.719). The left ALPS index predicted a 6- to 12-month cognitive prognosis (AUC = 0.857), with CSF proteins not mediating glymphatic-cognitive relationships. Conclusion: The association between imaging markers suggestive of altered perivascular clearance and cognitive decline in tuberculous meningitis underscores the potential mechanistic roles of the ALPS and CPV, positioning the ALPS index as a promising biomarker candidate for prognosis and cognitive dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.